178 related articles for article (PubMed ID: 9426325)
1. Preclinical and clinical strategies for development of telomerase and telomere inhibitors.
Sharma S; Raymond E; Soda H; Sun D; Hilsenbeck SG; Sharma A; Izbicka E; Windle B; Von Hoff DD
Ann Oncol; 1997 Nov; 8(11):1063-74. PubMed ID: 9426325
[TBL] [Abstract][Full Text] [Related]
2. Telomere length maintenance in aging and carcinogenesis.
Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
[TBL] [Abstract][Full Text] [Related]
3. Prospects for anti-neoplastic therapies based on telomere biology.
Stewart SA; Hahn WC
Curr Cancer Drug Targets; 2002 Mar; 2(1):1-17. PubMed ID: 12188917
[TBL] [Abstract][Full Text] [Related]
4. [Telomeres and telomerase activity: their role in aging and in neoplastic development].
Cottliar AS; Slavutsky IR
Medicina (B Aires); 2001; 61(3):335-42. PubMed ID: 11474884
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
Raymond E; Faivre S; Dieras V; Von Hoff D
Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
[TBL] [Abstract][Full Text] [Related]
6. Perifosine as a potential novel anti-telomerase therapy.
Holohan B; Hagiopian MM; Lai TP; Huang E; Friedman DR; Wright WE; Shay JW
Oncotarget; 2015 Sep; 6(26):21816-26. PubMed ID: 26307677
[TBL] [Abstract][Full Text] [Related]
7. Telomerase activity in cancer: a magic bullet or a mirage?
Soria JC; Vielh P; el-Naggar AK
Adv Anat Pathol; 1998 Mar; 5(2):86-94. PubMed ID: 9868515
[TBL] [Abstract][Full Text] [Related]
8. [Telomeres, telomerase and development of cancer].
Andersen TI
Tidsskr Nor Laegeforen; 1998 May; 118(13):2043-6. PubMed ID: 9656791
[TBL] [Abstract][Full Text] [Related]
9. Targeting the telosome: therapeutic implications.
Folini M; Gandellini P; Zaffaroni N
Biochim Biophys Acta; 2009 Apr; 1792(4):309-16. PubMed ID: 19419699
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
Tárkányi I; Aradi J
Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
[TBL] [Abstract][Full Text] [Related]
11. Hallmarks of telomeres in ageing research.
Shay JW; Wright WE
J Pathol; 2007 Jan; 211(2):114-23. PubMed ID: 17200948
[TBL] [Abstract][Full Text] [Related]
12. Telomerase: a potential therapeutic target for cancer.
Fletcher TM
Expert Opin Ther Targets; 2005 Jun; 9(3):457-69. PubMed ID: 15948667
[TBL] [Abstract][Full Text] [Related]
13. Agents that target telomerase and telomeres.
Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
[TBL] [Abstract][Full Text] [Related]
14. [Telomeres, telomerase and cancer].
Soria JC; Rixe O
Bull Cancer; 1997 Oct; 84(10):963-70. PubMed ID: 9435798
[TBL] [Abstract][Full Text] [Related]
15. [Telomeres and telomerase, new targets for anticancer chemotherapy].
Riou JF; Morjani H; Trentesaux C
Ann Pharm Fr; 2006 Mar; 64(2):97-105. PubMed ID: 16568010
[TBL] [Abstract][Full Text] [Related]
16. Introduction to telomeres and telomerase.
Bibby MC
Methods Mol Biol; 2002; 191():1-12. PubMed ID: 11951598
[No Abstract] [Full Text] [Related]
17. Telomeres, telomerase, and cancer: life on the edge of genomic stability.
Oulton R; Harrington L
Curr Opin Oncol; 2000 Jan; 12(1):74-81. PubMed ID: 10687733
[TBL] [Abstract][Full Text] [Related]
18. Telomeres and telomerases in cancer.
Novak KD
MedGenMed; 2003 Jan; 5(1):21. PubMed ID: 12827082
[No Abstract] [Full Text] [Related]
19. Telomerase and tumorigenesis.
Masutomi K; Hahn WC
Cancer Lett; 2003 May; 194(2):163-72. PubMed ID: 12757974
[TBL] [Abstract][Full Text] [Related]
20. Relationship between microsatellite instability and telomere shortening in colorectal cancer.
Takagi S; Kinouchi Y; Hiwatashi N; Nagashima F; Chida M; Takahashi S; Negoro K; Shimosegawa T; Toyota T
Dis Colon Rectum; 2000 Oct; 43(10 Suppl):S12-7. PubMed ID: 11052472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
